These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of a Drosophila activin receptor. Childs SR, Wrana JL, Arora K, Attisano L, O'Connor MB, Massagué J. Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9475-9. PubMed ID: 8415726 [Abstract] [Full Text] [Related]
3. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J. Mol Cell Biol; 1994 Jun 15; 14(6):3810-21. PubMed ID: 8196624 [Abstract] [Full Text] [Related]
4. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor. Kawabata M, Chytil A, Moses HL. J Biol Chem; 1995 Mar 10; 270(10):5625-30. PubMed ID: 7890683 [Abstract] [Full Text] [Related]
5. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL. Cell; 1993 Nov 19; 75(4):671-80. PubMed ID: 8242742 [Abstract] [Full Text] [Related]
6. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Takumi T, Moustakas A, Lin HY, Lodish HF. Exp Cell Res; 1995 Jan 19; 216(1):208-14. PubMed ID: 7813622 [Abstract] [Full Text] [Related]
7. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor. Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M. J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764 [Abstract] [Full Text] [Related]
8. The Drosophila activin receptor baboon signals through dSmad2 and controls cell proliferation but not patterning during larval development. Brummel T, Abdollah S, Haerry TE, Shimell MJ, Merriam J, Raftery L, Wrana JL, O'Connor MB. Genes Dev; 1999 Jan 01; 13(1):98-111. PubMed ID: 9887103 [Abstract] [Full Text] [Related]
9. zALK-8, a novel type I serine/threonine kinase receptor, is expressed throughout early zebrafish development. Yelick PC, Abduljabbar TS, Stashenko P. Dev Dyn; 1998 Apr 01; 211(4):352-61. PubMed ID: 9566954 [Abstract] [Full Text] [Related]
10. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. Xu J, McKeehan K, Matsuzaki K, McKeehan WL. J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768 [Abstract] [Full Text] [Related]
11. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. He WW, Gustafson ML, Hirobe S, Donahoe PK. Dev Dyn; 1993 Feb 17; 196(2):133-42. PubMed ID: 8395914 [Abstract] [Full Text] [Related]
12. Characterization of type I receptors for transforming growth factor-beta and activin. ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH. Science; 1994 Apr 01; 264(5155):101-4. PubMed ID: 8140412 [Abstract] [Full Text] [Related]
13. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. J Biol Chem; 1994 Jun 24; 269(25):16985-8. PubMed ID: 8006002 [Abstract] [Full Text] [Related]
14. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Tsuchida K, Mathews LS, Vale WW. Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11242-6. PubMed ID: 8248234 [Abstract] [Full Text] [Related]
15. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Mathews LS, Vale WW. Cell; 1991 Jun 14; 65(6):973-82. PubMed ID: 1646080 [Abstract] [Full Text] [Related]
16. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Xu J, Matsuzaki K, McKeehan K, Wang F, Kan M, McKeehan WL. Proc Natl Acad Sci U S A; 1994 Aug 16; 91(17):7957-61. PubMed ID: 8058741 [Abstract] [Full Text] [Related]
17. A mouse TGF-beta type I receptor that requires type II receptor for ligand binding. Suzuki A, Shioda N, Maeda T, Tada M, Ueno N. Biochem Biophys Res Commun; 1994 Feb 15; 198(3):1063-9. PubMed ID: 8117262 [Abstract] [Full Text] [Related]
18. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. Feng XH, Derynck R. EMBO J; 1997 Jul 01; 16(13):3912-23. PubMed ID: 9233801 [Abstract] [Full Text] [Related]
19. Cloning of a Drosophila melanogaster homologue of the mouse type-I bone morphogenetic proteins-2/-4 receptor: a potential decapentaplegic receptor. Okano H, Yoshikawa S, Suzuki A, Ueno N, Kaizu M, Okabe M, Takahashi T, Matsumoto M, Sawamoto K, Mikoshiba K. Gene; 1994 Oct 21; 148(2):203-9. PubMed ID: 7958946 [Abstract] [Full Text] [Related]
20. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K. Oncogene; 1993 Oct 21; 8(10):2879-87. PubMed ID: 8397373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]